Zobrazeno 1 - 10
of 1 269
pro vyhledávání: '"C. Nowak"'
Autor:
O. Burgos-Morales, M. Gueye, L. Lacombe, C. Nowak, R. Schmachtenberg, M. Hörner, C. Jerez-Longres, H. Mohsenin, H.J. Wagner, W. Weber
Publikováno v:
Materials Today Bio, Vol 11, Iss , Pp 100115- (2021)
Materials in nature have fascinating properties that serve as a continuous source of inspiration for materials scientists. Accordingly, bio-mimetic and bio-inspired approaches have yielded remarkable structural and functional materials for a plethora
Externí odkaz:
https://doaj.org/article/0172c2484ac6437a8d841f5c952f3b46
Publikováno v:
European Journal of Psychotraumatology, Vol 12, Iss 1 (2021)
Background: Prevalence rates of posttraumatic stress disorder and depression are high among refugees in Germany. However, knowledge on subjective as well as objective need for psychotherapy and utilization of psychotherapeutic treatment is scarce. Bo
Externí odkaz:
https://doaj.org/article/cb83f3c3c54d48dbb53d341e71528988
Autor:
C. Nowak, X. W. Zhou
Publikováno v:
Physical Chemistry Chemical Physics. 25:8369-8375
The interplay between hydrogen and dislocations (e.g., core and elastic energies, and dislocation–dislocation interactions) has implications on hydrogen embrittlement but is poorly understood.
Publikováno v:
Outlook on Agriculture. 51:423-434
CGIAR consists of a network of international publicly funded agricultural research for development institutes. Over five decades it has worked to increase food abundance, reduce hunger and poverty rates, and lower the geographical footprint of agricu
Autor:
Evelien Schaafsma, Walburga Croteau, Mohamed ElTanbouly, Elizabeth C. Nowak, Nicole C. Smits, Jie Deng, Aurelien Sarde, Cecilia A. Webber, Dina Rabadi, Chao Cheng, Randolph Noelle, J. Louise Lines
Publikováno v:
Cancer Immunology Research. 11:38-55
V domain immunoglobulin suppressor of T-cell activation (VISTA) is a premier target for cancer treatment due to its broad expression in many cancer types and enhanced expression upon development of adaptive immune checkpoint resistance. In the CT26 c
Publikováno v:
International Journal of Hydrogen Energy. 47:32732-32740
Autor:
Thomas W. K. Broughton, Mohamed A. ElTanbouly, Evelien Schaafsma, Jie Deng, Aurélien Sarde, Walburga Croteau, Jiannan Li, Elizabeth C. Nowak, Rodwell Mabaera, Nicole C. Smits, Anna Kuta, Randolph J. Noelle, J. Louise Lines
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The role of negative checkpoint regulators (NCRs) in human health and disease cannot be overstated. V-domain Ig-containing Suppressor of T-cell Activation (VISTA) is an Ig superfamily protein predominantly expressed within the hematopoietic compartme
Externí odkaz:
https://doaj.org/article/aa81c03c2d9d49e181064387b1d2ad4b
Autor:
J. Louise Lines, Randolph Noelle, Chao Cheng, Dina Rabadi, Cecilia A. Webber, Aurelien Sarde, Jie Deng, Nicole C. Smits, Elizabeth C. Nowak, Mohamed ElTanbouly, Walburga Croteau, Evelien Schaafsma
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145f533a92db95a15f1f62f5e7302242
https://doi.org/10.1158/2326-6066.22546457
https://doi.org/10.1158/2326-6066.22546457
Data from VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance
Autor:
J. Louise Lines, Randolph Noelle, Chao Cheng, Dina Rabadi, Cecilia A. Webber, Aurelien Sarde, Jie Deng, Nicole C. Smits, Elizabeth C. Nowak, Mohamed ElTanbouly, Walburga Croteau, Evelien Schaafsma
V domain immunoglobulin suppressor of T-cell activation (VISTA) is a premier target for cancer treatment due to its broad expression in many cancer types and enhanced expression upon development of adaptive immune checkpoint resistance. In the CT26 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f574f1776e452a163ae57c8bb123c59
https://doi.org/10.1158/2326-6066.c.6551180
https://doi.org/10.1158/2326-6066.c.6551180
Autor:
J. Louise Lines, Randolph Noelle, Chao Cheng, Dina Rabadi, Cecilia A. Webber, Aurelien Sarde, Jie Deng, Nicole C. Smits, Elizabeth C. Nowak, Mohamed ElTanbouly, Walburga Croteau, Evelien Schaafsma
Supplementary Figure S4. Additional data supporting Figure 6. In the I/V model, BALB/c mice were administered 100k CT26 cells and treated when tumors reached a size of 40mm3 with isotype (I) or anti-VISTA (V). In the CPV model, BALB/c mice were admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62948b0a549eec09ee666601258cb444
https://doi.org/10.1158/2326-6066.22546460.v1
https://doi.org/10.1158/2326-6066.22546460.v1